Introduction
============

Cardiac arrest (CA) is a leading cause of mortality that affects \>325,000 people in the United States of America each year. Sudden cardiac arrest may lead to a loss of blood supply, ischemia and hypoxia in various organs of the body, causing serious damage to organ function and potentially mortality ([@b1-etm-0-0-8039],[@b2-etm-0-0-8039]). Although knowledge and proficiency of cardiopulmonary resuscitation (CPR) have expanded amongst the general population, the rate of survival to hospital discharge following pulseless cardiac arrest remains low ([@b2-etm-0-0-8039]). However, although resumption of spontaneous circulation (ROSC) following prolonged and complete, whole-body ischemia is an unnatural pathophysiological state created by CPR, in a recent study of 24,132 patients in the United Kingdom who were admitted to critical care units following a cardiac arrest, the in-hospital mortality rate was 71% ([@b3-etm-0-0-8039]).

High rates of morbidity and mortality are observed in patients in which ROSC occurs following out-of-hospital CA, which is largely due to the cerebral and cardiac dysfunction that accompanies prolonged whole-body ischemia ([@b4-etm-0-0-8039],[@b5-etm-0-0-8039]), referred to as post cardiac arrest syndrome (PACS). PACS is comprised of anoxic brain injury, post-cardiac arrest myocardial dysfunction, systemic ischemia/reperfusion (I/R) response and persistent precipitating pathology ([@b6-etm-0-0-8039]). The intestine is equally or potentially even more sensitive to ischemia compared with the brain or muscles following CPR ([@b7-etm-0-0-8039]). CA causes a prolonged decrease of blood flow to the intestine ([@b7-etm-0-0-8039]). The I/R response in the intestine increases intestinal barrier permeability and results in the translocation of pathogenic bacteria and endotoxins, which is considered as an important mechanism leading to the initiation of sepsis and multiple organ failure ([@b8-etm-0-0-8039],[@b9-etm-0-0-8039]).

Mild therapeutic hypothermia (MTH), also referred to as targeted temperature management, was introduced into the clinical management of cardiac arrest survivors \>10 years ago ([@b10-etm-0-0-8039],[@b11-etm-0-0-8039]). Therapeutic hypothermia (TH) is now recommended in international resuscitation guidelines, and its use has been extended to cardiac arrest of other origins, with other dysrhythmias and in the hospital setting ([@b12-etm-0-0-8039],[@b13-etm-0-0-8039]). Previous studies have confirmed that TH and postconditioning with sevoflurane affected the expression and activity of several small intestinal proteins that may be involved in intestinal I/R-mediated events following successful CPR ([@b14-etm-0-0-8039],[@b15-etm-0-0-8039]).

Ulinastatin (UTI), a urinary trypsin inhibitor, is a serine protease inhibitor which has anti-inflammatory properties at sites of inflammation and has been widely used as a treatment for patients with inflammatory disorders. UTI has been demonstrated to represent an attractive 'rescue' therapeutic option for endotoxin-associated inflammatory disorders including disseminated intravascular coagulation, acute lung injury and acute liver injury ([@b16-etm-0-0-8039]--[@b18-etm-0-0-8039]). UTI treatment at the onset of CPR also alleviates the inflammatory responses following resuscitation and improves neurological function ([@b19-etm-0-0-8039],[@b20-etm-0-0-8039]). In a meta-analysis, UTI decreased the plasma levels of pro-inflammatory cytokines and increased the levels of anti-inflammatory cytokines in patients from China and Japan undergoing cardiac surgery with cardiopulmonary bypass. UTI treatment may have protective effects on myocardial injury and may increase the frequency of auto resuscitation, and shorten the duration of intubation and mechanical ventilation ([@b21-etm-0-0-8039]).

However, the effects of UTI combined with MTH on intestinal barrier dysfunction *in vivo* have yet to be determined. The aim of the present study was to investigate the effect of UTI alone or combined with MTH on intestinal barrier dysfunction following cardiopulmonary resuscitation in rats.

Materials and methods
=====================

### Animals and chemicals

The experiments performed in the present study were approved by The Animal Research Committee of Xiangya Hospital of Central South University (Changsha, China), and the animals were housed and subsequently used in the Experimental Animal Center of the Xiangya Hospital of Central South University (Changsha, China). A total of 25 adult male Sprague-Dawley rats (400±40 g) were purchased from Shanghai Laboratory Animal Center, Chinese Academy of Science. During the entire experiment the animals were housed in stainless steel cages (1 rat/cage) at conventional controlled conditions (temperature 25±2°C; relative humidity 50±10%; 12-h light: dark cycle) and had *ad libitum* access to standard laboratory food and tap water. The rats were randomly assigned to five groups of 5 rats each. The first group was the sham group, in which anesthesia, endotracheal intubation and insertion of arterial and venous catheters were performed, and asphyxiated CA was not induced. Rats in the other four groups, including the control group, the UTI group, the MTH group and the combined group (UTI combined with MTH) were established based on the rat model of CPR following asphyxiated CA. Rats in these four groups underwent the following interventions: Anesthesia; endotracheal intubation; and insertion of arterial and venous catheters; and asphyxiated CA. The UTI group received 1.5 mg/100 g UTI (Guangdong Techpool Bio-pharma, Co., Ltd.) at the onset of resuscitation within the first 2 min, whereas the MTH group were cooled over 5 min through the application of 70% isopropyl alcohol to their ventral surface followed by hand fanning after 2 min of ROSC to achieve a target rectal temperature (32.5±0.5°C) in 30 min. On reaching the target temperature of 32.5±0.5°C, it was maintained with a cooling blanket \[model no, P&C-A II; Heng Bang (Beijing) Technology Development Co., Ltd.\] for an additional 6 h. For rats not in the MTH or UTI and MTH groups, the rectal temperature was maintained at 37°C for an additional 6 h.

### Establishment of a rat model of CPR following asphyxiated CA

The rats acclimated to conditions for 1 week prior to the experiment and fasted overnight prior to surgery, with *ad libitum* access to water. The asphyxiated CA rat model was induced as previously described ([@b22-etm-0-0-8039]). Briefly, rats were anesthetized with 10% chloral hydrate 0.3 ml/100 g (300 mg/kg), orally intubated and mechanically ventilated using a small-animal ventilator (PE 200 catheter) to maintain an end-tidal CO~2~ level between 35 and 45 mmHg. The rats were intravenously injected with 0.2 mg/100 g vecuronium bromide to prevent spontaneous respiration. The left femoral artery and vein were separately cannulated with PE-50 tubes to measure arterial pressure, heart rate (HR) and arterial blood gas and in order to provide fluid and medications. A standard II lead electrocardiogram was also recorded. Following surgical preparation, the animals were observed for 30 min to ensure hemodynamic stability. Asphyxiated CA was induced by switching off the ventilator for 30 min. When the electrocardiogram indicated ventricular fibrillation (VF), no pulse electrical activity or electrical static and mean arterial pressure (MAP) below 20 mmHg, this was defined as CA ([@b22-etm-0-0-8039]).

Cardiopulmonary resuscitation was performed on the asphyxiated CA rats after 1 min of CA. CPR was performed with continuous ventilation at a tidal volume of 0.50 ml/100 g with 21% O~2~, at a frequency of 100 breaths/min and external cardiac compressions at a rate of 200/min. The compression depth was 1/3 of the anteroposterior diameter of the thorax, along with an intravenous injection of 0.02 mg/100 g epinephrine. If VF persisted or an organized rhythm with a mean aortic pressure ≤25 mmHg ensued, defibrillation was attempted after 1 min of chest compression by delivering up to 2 J electric shock biphasic waveform electrical shocks across the chest (Heartstream XL; Philips Medical Systems, Inc.). After 30 sec of CPR, 1 3-J monophasic electric shock was administered. Successful CPR was defined as achievement of ROSC, and ROSC was defined as the return of an organized rhythm with a systolic pressure \>80 mmHg for \>5 min ([@b22-etm-0-0-8039]). CPR was considered to have failed if no sign of ROSC was observed during the 5 min post-resuscitation period ([@b22-etm-0-0-8039]).

### Assessment of the circulatory function

MAP, HR and rectal temperature were recorded for all the animals during the experimental process.

### Histological examination

All rats were re-anesthetized as described above \[10% chloral hydrate 0.3 ml/100 g (300 mg/kg)\] and then sacrificed by cervical spinal cord dissection after 6 h treatment. No signs of peritonitis were observed. Tissue section samples of the ileum (1.0 cm) were snap-frozen in liquid nitrogen and stored at −70°C prior to analysis. For analysis, the samples were cut with a cryostat into 2×2 mm thick sections, fixed in 2.5% glutaric acid at room temperature for 24 h, 2.0% osmic acid for 2 h and subsequently dehydrated in a series of 50, 70, 90 and 100% acetone for 3 cycles, 10 min/cycle. Following dehydration, all the samples were infused for 24 h in 1:1 epoxy resin mixture and pure acetone. The samples were then embedded in ethoxyline resin, dodecenylsuccinic anhydride, methyl nadic anhydride, dimethylaminomethyl phenol at 60°C for 24 h. Following embedding, the samples were dyed with 1% toluidine blue at 50°C for 20 min and cut with an LKB-III ultrathin slicing machine (LKB Ltd.) into 500 Å slices. The slices were then double-stained with 7.7% uranium acetate for 10 min and 4% lead nitrate for 5 min at room temperature and examined using a HT7700 type transmission electron microscope (Hitachi, Ltd.).

### Malondialdehyde (MDA) and superoxide dismutase (SOD) assays in intestinal tissues

Intestinal tissues (1.0 cm segments from 5 cm of the terminal ileum) were harvested, frozen immediately and stored at −80°C until assessment. The levels of MDA in the ileum samples were measured using MDA detection kit (cat. no. A003-1; Nanjing Jiancheng Bioengineering Institute), according to the manufacturer\'s protocol. Briefly, tissues from the small intestine were homogenized in 1.5% cold KCl solution at a ratio of 1:10 (weight: Volume). The lipid peroxide level in the supernatant (1,000 × g; 10 min; room temperature) was measured as described previously ([@b23-etm-0-0-8039]). Absorbance of the reaction was measured at 532 nm (Shimadzu UV-1700; Shimadzu Corporation). The lipid peroxide levels are expressed as nmol of MDA/mg of tissue protein. The content of MDA in the intestine was calculated according to the following formula: MDA (nmol/mg protein)={\[(sample tube absorbance-blank tube absorbance)/(standard tube absorbance-blank tube absorbance)\] × standard concentration}/protein content.

Intestinal SOD activity was determined using Superoxide Dismutase assay kit (cat. no. A001-3) according to the manufacturer\'s protocol (Nanjing Jiancheng Bioengineering Institute). The tissue homogenate and reagent were placed in a water bath at 37°C for 40 min following thorough mixing. After 10 min at room temperature, the absorbance value of each supernatant was determined at 550 nm. The activity of SOD in the intestine was calculated according to the following formula: SOD (U/ml)=\[(control tube absorbance-determination tube absorbance)/control tube absorbance\]/(50% × reaction system dilution multiple × sample dilution multiple).

### Statistical analysis

All results statistics were analyzed by GraphPad Prism v.5 (GraphPad Software, Inc.) for statistical evaluation. Data are expressed as the mean ± standard error of the mean. The statistical analysis of differences between experimental groups was performed using a Student\'s t-test. A one-way analysis of variance followed by Student-Newman-Keuls test was used to analyze the differences among three experimental groups. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Changes in physiological parameters in rats from each group

MAP, HR and rectal temperature of each group were measured prior to euthanizing the rats following the various treatments for 6 h after ROSC ([Fig. 1](#f1-etm-0-0-8039){ref-type="fig"}). MAP and HR values of each group were not significantly different ([Fig. 2A and B](#f2-etm-0-0-8039){ref-type="fig"}). The MTH group and combined group rats successfully attained the target temperature, and the other three groups all survived at a normal temperature ([Fig. 2C](#f2-etm-0-0-8039){ref-type="fig"}).

### Histological changes

The epithelial cells of the small intestinal mucosa were altered following different treatments for 6 h ([Fig. 3](#f3-etm-0-0-8039){ref-type="fig"}). [Fig. 3A](#f3-etm-0-0-8039){ref-type="fig"} demonstrates that the sham group had the normal epithelial cells, whereas the epithelial cells in the rats in the combined group exhibited indications of slight changes including mitochondrial edema ([Fig. 3C](#f3-etm-0-0-8039){ref-type="fig"}). The epithelial cells in the UTI and the MTH groups demonstrated more marked pathological changes, including shortened and partially opened intercellular tight junctions and disorderly epithelial cell surface microvilli ([Fig. 3D and E](#f3-etm-0-0-8039){ref-type="fig"}). The control group exhibited the most notable changes to the epithelial cells, including disappearance of the intercellular space and broken microvilli, and the nucleus had indications of chromatin concentration and edge accumulation ([Fig. 3B](#f3-etm-0-0-8039){ref-type="fig"}).

### MDA and SOD expression assays in intestinal tissue samples

After the 6 h treatment steps, the levels of MDA in the intestine of the sham, combined, UTI and MTH groups were decreased when compared with the control group (all P\<0.05; [Table I](#tI-etm-0-0-8039){ref-type="table"}; [Fig. 4A](#f4-etm-0-0-8039){ref-type="fig"}). The MDA levels in the combined, UTI and MTH groups were significantly increased compared with the sham group (P\<0.05) and the MDA levels in UTI and MTH groups were significantly increased compared with the combined group (P\<0.05), but there were no significant difference between the UTI and MTH groups (P\>0.05). The results indicated that the levels of MDA in each group were significantly different, with the exception of the comparison between the UTI and MTH groups.

The levels of SOD in the intestinal tissues of the sham, combined, UTI and MTH groups were significantly increased compared with the control group (P\<0.05; [Fig. 4B](#f4-etm-0-0-8039){ref-type="fig"}; [Table II](#tII-etm-0-0-8039){ref-type="table"}). The SOD levels in the UTI and MTH groups were decreased compared with the combined group (P\<0.05) and there was no significant difference between the UTI and MTH groups (P\>0.05). These results suggested that the levels of SOD in each group was statistically significant, with the exception of the comparison between the UTI and MTH groups.

Taken together, the results indicated that when compared with the control group, the sham group exhibited relatively decreased levels of MDA and increased levels of SOD. However, the UTI and MTH groups demonstrated decreased levels of MDA and increased levels of SOD compared with the sham group, but there was no difference between them. The combined group exhibited the lowest levels of MDA and the highest levels of SOD.

Discussion
==========

Intestinal ischemia is one of the major causes leading to multiple organ failure in patients in intensive care facilities and has been described as a consequence of low splanchnic blood flow following cardiac arrest ([@b7-etm-0-0-8039]). The intestine is not only a vulnerable target to ischemia but a potential secondary source of inflammatory cytokines. Clinically, intestinal injuries following cardiac arrest are often underestimated, even though they represent a potentially devastating complication following successful resuscitation ([@b24-etm-0-0-8039]). Loss of intestinal barrier integrity serves a pivotal role in the development of systemic inflammatory response syndrome, sepsis and multiple organ failure. The formation of the intestinal mucosal barrier may be associated with the peculiar anatomical-physiological arrangements of the intestinal villi and the epithelial cells ([@b23-etm-0-0-8039]). Intestinal mucosal surfaces are lined by epithelial cells. These cells establish a barrier between occasionally hostile external environments and the internal milieu. The intestinal epithelial cells serve as a central mediator of interactions between the mucosal immune system and luminal contents, including dietary antigens and microbial products ([@b25-etm-0-0-8039]). Tight junctions seal the paracellular space between epithelial cells, are the rate-limiting step in transepithelial transport and are the principal determinant of mucosal permeability to regulate the absorption of nutrients ([@b25-etm-0-0-8039]). Therefore, the epithelium and tight junctions are modulators of mucosal homeostasis.

Previous studies have suggested that UTI may attenuate multiple organ injury in a cardiac arrest model by suppressing inflammation, central autophagy and apoptosis, and antioxidative mechanisms ([@b20-etm-0-0-8039],[@b26-etm-0-0-8039],[@b27-etm-0-0-8039]). The present study demonstrated that in the in the control group, the epithelial cells demonstrated the most notable pathological changes; although the rats in this group achieved ROSC following CA, they did not receive any effective intervention and the small intestinal mucosa endured an unnatural pathophysiological ischemic state as a result of CA, which caused a prolonged decrease of blood flow to the intestinal wall ([@b7-etm-0-0-8039]). Even when treated with UTI or MTH, the epithelial cells in rats demonstrated pathophysiological changes, including alterations to the tight junctions and epithelial cell surface microvilli when compared with the sham group. These changes suggested that UTI or MTH only had a partly protective effect on the small intestinal mucosa barrier. The rats that underwent the combined treatment had epithelial cells that presented with only slight pathophysiological changes, including mitochondrial edema, but in all other respects were highly similar to the sham group. The results of the present study suggest that UTI combined with MTH may significantly decrease I/R injury in the small intestinal mucosa.

The levels of the MDA and SOD in the intestinal tissues were additionally examined in the present study. The results of the MDA and SOD assays corroborated the results of the electron microscopy examination of the ileum tissues. UTI and MTH separately partly protected against injury induced as a result of I/R of the small intestinal mucosa; however, UTI combined with MTH significantly improved intestinal mucosa barrier function in rats that achieved ROSC following CA. MDA is often used as an indicator of oxidative stress, as it is degradation product of polyunsaturated lipids by reactive oxygen species and may cause toxic stress in cells, whereas SOD is important antioxidant in cells exposed to oxygen ([@b8-etm-0-0-8039]). Therefore, UTI combined with MTH may improve antioxidant defense and suppress the oxidative stress in the small intestinal mucosa.

The intestinal mucosa is an organ with a rich blood supply and extensive metabolic activities, and therefore it is also vulnerable to metabolic disorders caused by hypoxia. In addition, I/R injury often occurs when reperfusion is achieved due to abnormal oxygen metabolism, the generation of oxygen free radicals, calcium overload and endothelial swelling ([@b28-etm-0-0-8039]). When intestinal injury is caused by reperfusion, the primary characteristics are expression of adhesion molecules, production of inflammatory cytokines, activation of the complement system, infiltration of neutrophil and release of proteases, and UTI may directly inhibit the production of these molecular and cellular factors, or directly affect neutrophils, inhibiting its infiltration into the tissues which would otherwise cause inflammatory damage ([@b29-etm-0-0-8039]). Previous studies have also confirmed that UTI had a significant effect in protecting the mucosal barrier function particularly against early pathological changes ([@b30-etm-0-0-8039],[@b31-etm-0-0-8039]) and that UTI significantly ameliorated injury to the small intestinal and subsequent bacterial translocation by inhibiting degranulation of mast cells in septic rats ([@b32-etm-0-0-8039]). In addition, a protective effect of UTI on intestinal injury during the perioperative period of acute superior mesenteric artery ischemia has also been observed ([@b29-etm-0-0-8039]). Previous studies additionally suggested that UTI significantly decreased the levels of MDA in the plasma of patients following early CPR ([@b26-etm-0-0-8039]), and the systemic administration of UTI also largely restored SOD in CA models ([@b20-etm-0-0-8039]). The present study confirmed that UTI treatment alone or combined with MTH may serve a protective role by suppressing the expression of SOD and MDA in rats. Patients are prone to multiple organ dysfunction following CPR, but effective treatments are limited at present. UTI has been widely applied in clinical practice in China, and previous studies have confirmed its protective effects ([@b18-etm-0-0-8039]--[@b21-etm-0-0-8039]). The present study may provide novel insights into the development of potential therapeutics for clinical treatment of patients following CPR.

Therapeutic hypothermia is now recommended in the international resuscitation guidelines to treat patients post-CA ([@b12-etm-0-0-8039]). Hypothermia applied as a rescue therapy for intestinal I/R resulted in decreased mortality even following returning to normothermia ([@b33-etm-0-0-8039],[@b34-etm-0-0-8039]). Hypothermic protection during early reperfusion appears to be mediated by several events, including prevention of intestinal and pulmonary neutrophil infiltration, a decrease in oxidative stress in the ileum, and preservation of cardiac and hepatic energy metabolism. Moderate hypothermia may improve outcomes in clinical conditions associated with intestinal I/R ([@b33-etm-0-0-8039],[@b34-etm-0-0-8039]). However, relatively few studies have determined the mechanisms underlying the protective effects of MTH on small intestinal injury. Perioperative hypothermia decreased the activity of the antioxidant enzymes catalase and SOD, decreased glutathione levels and increased lipid peroxidation in the scar tissue of colonic anastomoses in rats ([@b35-etm-0-0-8039]--[@b37-etm-0-0-8039]). Hypothermia altered the expression and activity of several small intestinal proteins that may be involved in intestinal I/R-mediated events following successful cardiopulmonary resuscitation ([@b14-etm-0-0-8039]).

The present study has several limitations: Firstly, only the small intestine changes within 6 h after CPR in rats were observed, but without real-time dynamic monitoring; secondly, the pharmacological mechanisms of MTH and UTI activity were not examined in further detail, to provide additional understanding of the pathways underlying the protective effects of MTH and UTI; thirdly, although UTI and MTH have been widely used in the clinical treatment of patients following CPR, there are certain differences between animal models and actual clinical situations, and therefore the results of the present study may not accurately reflect the results of any potential clinical application; fourthly, as the levels of MDA content and SOD activity are the primary indicators for evaluating the degree of oxidative stress damage in various tissues, and are considered to reflect the initial stage of oxidative stress and I/R injury changes, no other molecules or biomarkers were analyzed in the present study. However, additional molecules or biomarkers involved in intestinal barrier injury will be examined in subsequent studies.

In conclusion, both UTI and MTH alone demonstrated partial protective effects on intestinal mucosal barrier function; however, UTI combined with MTH exhibited an improved protective effect by suppressing oxidative stress in the small intestinal mucosa following CPR in rats.
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![Flow chart of the experimental groups. SD, Sprague-Dawley; Ctrl, control; UTI, ulinastatin; MTH, mild therapeutic hypothermia; TEM, transmission electron microscopy; SOD, superoxide dimutase; MDA, malondialdehyde.](etm-18-05-3861-g00){#f1-etm-0-0-8039}

![Changes in physiological parameters in the rats from each experimental group. (A) MAP of each treatment group following ROSC. There were no significant differences between the groups (P\>0.05). (B) Heart rate of each group following ROSC. There were no significant differences between the groups (P\>0.05). (C) The MTH group and the combined group rats successfully achieved mild hypothermia, and the rats in the other three groups maintained their normal rectal temperature. MAP, mean arterial pressure; ROSC, resumption of spontaneous circulation; MTH, mild therapeutic hypothermia; UTI, ulinastatin.](etm-18-05-3861-g01){#f2-etm-0-0-8039}

![Histological changes in the intestinal tissues isolated from rats in each experimental group. (A) Sham group. Intestinal epithelial cells were arranged neatly (blue arrow), and the epithelial cells were tightly connected and dense (red arrow). (B) Control group. The tight junctions between the epithelial cells disappeared (red arrow), the microvilli of the epithelial cells exhibited necrosis (blue arrow) and the nucleus of the epithelial cells had contracted (yellow arrow). (C) Combined group. Lymphocytes infiltrated under the small intestine epithelium (yellow arrow), tight junctions between epithelial cells were tightly connected (red arrow), and there was evidence of mitochondrial edema (blue arrow). (D) Ulinastatin group. Mitochondrial edema (yellow arrow) was observed and tight junctions between epithelial cells were partially open (red arrow). The microvilli of the epithelial cells were arranged in a disorderly manner and varied in height (blue arrow). (E) Mild therapeutic hypothermia group. The tight junctions between the epithelial cells were open (red arrow), the microvilli were neatly arranged without necrosis and there was evidence of mitochondrial edema (blue arrow). The nucleus had not condensed (yellow arrow). Magnification, ×40,000.](etm-18-05-3861-g02){#f3-etm-0-0-8039}

###### 

MDA and SOD expression measurements in intestinal tissue samples from rats from each experimental group. (A) Expression of MDA in each group. There was no significant difference between the UTI and MTH groups (P\>0.05). (B) Expression of SOD in each group. There was no significant difference between the UTI and MTH groups (P\>0.05). \*P\<0.05, Sham vs. Control; ^\#^P\<0.05, Sham vs. Combined; ^◊^P\<0.05, Sham vs. UTI; and ^§^P\<0.05, and Sham vs. MTH. ^\#\#^P\<0.05, Control vs. Combined; ^◊◊^P\<0.05, Control vs. UTI; \*\*P\<0.05, Control vs. MTH; ^§§^P\<0.05, Combined vs. UTI; and \*\*\*P\<0.05, Combined vs. MTH. MDA, malondialdehyde; SOD, superoxide dismutase; UTI, ulinastatin; MTH, mild therapeutic hypothermia.
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###### 

Levels of MDA in each group.

  Group      Sample   MDA (nmol/mg protein)
  ---------- -------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sham       5        3.61±0.06^[a](#tfn2-etm-0-0-8039){ref-type="table-fn"}--[d](#tfn5-etm-0-0-8039){ref-type="table-fn"}^
  Control    5        4.99±0.10^[a](#tfn2-etm-0-0-8039){ref-type="table-fn"},[e](#tfn6-etm-0-0-8039){ref-type="table-fn"}--[g](#tfn8-etm-0-0-8039){ref-type="table-fn"}^
  UTI        5        4.39±0.12^[b](#tfn3-etm-0-0-8039){ref-type="table-fn"},[e](#tfn6-etm-0-0-8039){ref-type="table-fn"},[h](#tfn9-etm-0-0-8039){ref-type="table-fn"},[i](#tfn10-etm-0-0-8039){ref-type="table-fn"}^
  MTH        5        4.43±0.09^[c](#tfn4-etm-0-0-8039){ref-type="table-fn"},[f](#tfn7-etm-0-0-8039){ref-type="table-fn"},[h](#tfn9-etm-0-0-8039){ref-type="table-fn"}^
  Combined   5        3.79±0.14^[d](#tfn5-etm-0-0-8039){ref-type="table-fn"},[g](#tfn8-etm-0-0-8039){ref-type="table-fn"},[i](#tfn10-etm-0-0-8039){ref-type="table-fn"}^

Data are presented as the mean ± standard error of the mean.

P\<0.05, Sham vs. Control

P\<0.05, Sham vs. Combined

P\<0.05, Sham vs. UTI

P\<0.05, and Sham vs. MTH.

P\<0.05, Control vs. Combined

P\<0.05, Control vs. UTI

P\<0.05, Control vs. MTH

P\<0.05, Combined vs. UTI

P\<0.05, Combined vs. MTH. MDA, malondialdehyde; SOD, superoxide dismutase; UTI, ulinastatin; MTH, mild therapeutic hypothermia.

###### 

Levels of SOD in the intestinal tissues of each group.

  Group      Samples   SOD (U/ml)
  ---------- --------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sham       5         46.46±1.88^[a](#tfn12-etm-0-0-8039){ref-type="table-fn"}--[d](#tfn15-etm-0-0-8039){ref-type="table-fn"}^
  Control    5         190.20±7.68^[a](#tfn12-etm-0-0-8039){ref-type="table-fn"},[e](#tfn16-etm-0-0-8039){ref-type="table-fn"}--[g](#tfn18-etm-0-0-8039){ref-type="table-fn"}^
  UTI        5         130.61±10.426^[b](#tfn13-etm-0-0-8039){ref-type="table-fn"},[e](#tfn16-etm-0-0-8039){ref-type="table-fn"},[h](#tfn19-etm-0-0-8039){ref-type="table-fn"},[i](#tfn20-etm-0-0-8039){ref-type="table-fn"}^
  MTH        5         128.53±5.836^[c](#tfn14-etm-0-0-8039){ref-type="table-fn"},[f](#tfn17-etm-0-0-8039){ref-type="table-fn"},[h](#tfn19-etm-0-0-8039){ref-type="table-fn"}^
  Combined   5         179.15±11.17^[d](#tfn15-etm-0-0-8039){ref-type="table-fn"},[g](#tfn18-etm-0-0-8039){ref-type="table-fn"},[i](#tfn20-etm-0-0-8039){ref-type="table-fn"}^

Data are presented as the mean ± standard error of the mean.

P\<0.05, Sham vs. Control

P\<0.05, Sham vs. Combined

P\<0.05, Sham vs. UTI

P\<0.05, and Sham vs. MTH.

P\<0.05, Control vs. Combined

P\<0.05, Control vs. UTI

P\<0.05, Control vs. MTH

P\<0.05, Combined vs. UTI

P\<0.05, Combined vs. MTH. SOD, superoxide dismutase; UTI, ulinastatin; MTH, mild therapeutic hypothermia.
